Evidence map›Paper›PMID 30662304›Full record

ArticleJournal of ginseng research2019

Compound K, a ginsenoside metabolite, plays an antiinflammatory role in macrophages by targeting the AKT1-mediated signaling pathway.

Jeong-Oog Lee, Eunju Choi, Kon Kuk Shin, Yo Han Hong, Han Gyung Kim, Deok Jeong, Mohammad Amjad Hossain, Hyun Soo Kim, Young-Su Yi, Donghyun Kim and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of ginseng research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Pharmaceutical biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Jeong-Oog LeeDepartment of Aerospace Information Engineering, Bio-Inspired Aerospace Information Laboratory, Konkuk University, Seoul, Republic of Korea.
Eunju ChoiDepartment of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea.
Kon Kuk ShinDepartment of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea.
Yo Han HongDepartment of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea.
Han Gyung KimDepartment of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea.
Deok JeongDepartment of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea.
Mohammad Amjad HossainDepartment of Veterinary Physiology, College of Medicine, Chonbuk National University, Iksan, Republic of Korea.
Hyun Soo KimBasic Research & Innovation Division, R&D Center, Amorepacific Corporation, Yongin, Republic of Korea.
Young-Su YiDepartment of Pharmaceutical Engineering, Cheongju University, Cheongju, Republic of Korea.
Donghyun KimBasic Research & Innovation Division, R&D Center, Amorepacific Corporation, Yongin, Republic of Korea.
Eunji KimDepartment of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea.
Jae Youl ChoDepartment of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea.
Sungkyunkwan University · KRAmorepacific (South Korea) · KRCheongju University · KRJeonbuk National University · KRKonkuk University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCompound K (CK) is an active metabolite of ginseng saponin, ginsenoside Rb1, that has been shown to have ameliorative properties in various diseases. However, its role in inflammation and the underlying mechanisms are poorly understood. In this report, the antiinflammatory role of CK was investigated in macrophage-like cells.

methodsThe CK-mediated antiinflammatory mechanism was explored in RAW264.7 and HEK293 cells that were activated by lipopolysaccharide (LPS) or exhibited overexpression of known activation proteins. The mRNA levels of inflammatory genes and the activation levels of target proteins were identified by quantitative and semiquantitative reverse transcription polymerase chain reaction and Western blot analysis.

resultsCK significantly inhibited the mRNA expression of inducible nitric oxide synthase and tumor necrosis factor-α and morphological changes in LPS-activated RAW264.7 cells under noncytotoxic concentrations. CK downregulated the phosphorylation of AKT1, but not AKT2, in LPS-activated RAW264.7 cells. Similarly, CK reduced the AKT1 overexpression-induced expression of aldehyde oxidase 1, interleukin-1β, interferon-β, and tumor necrosis factor-α in a dose-dependent manner.

conclusionOur results suggest that CK plays an antiinflammatory role during macrophage-mediated inflammatory actions by specifically targeting the AKT1-mediated signaling pathway.

Indexed as

AKT1Compound KInflammatory responseMacrophage

Identifiers

PMID30662304
PMCPMC6323178
OpenAlexW2898103265

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.